Melissa M. Berrien-Elliott

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

Christopher A. Miller, Matthew K. Matlock, L. Trani, 2017, Blood.

Improving natural killer cell cancer immunotherapy

T. Fehniger, Melissa M. Berrien-Elliott, R. Romee, 2015, Current opinion in organ transplantation.

Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia.

F. Gao, F. Gao, P. Westervelt, 2020, Cancer discovery.

Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis

Jonathan R. Brestoff, D. Margolis, M. Colonna, 2020, Science Translational Medicine.

Memory-Like Natural Killer Cells

T. Fehniger, A. Cashen, Melissa M. Berrien-Elliott, 2018, Blood.

Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses.

T. Fehniger, Melissa M. Berrien-Elliott, Julia A. Wagner, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.

P. Greenberg, H. Yagita, R. DiPaolo, 2013, Cancer research.

Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development.

P. Kingsley, K. McGrath, J. Palis, 2020, Developmental cell.

CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas.

F. Gao, F. Gao, J. Dipersio, 2020, Blood.

Inflammation programs self‐reactive CD8+ T cells to acquire T‐box‐mediated effector function but does not prevent deletional tolerance

M. Donlin, R. Teague, Jinyun Yuan, 2014, Journal of leukocyte biology.

Memory-like natural killer cells for cancer immunotherapy.

T. Fehniger, Melissa M. Berrien-Elliott, Pamela Wong, 2020, Seminars in hematology.

Neuropilin-1 Expression Is Induced on Tolerant Self-Reactive CD8+ T Cells but Is Dispensable for the Tolerant Phenotype

E. Hsueh, R. Teague, Jinyun Yuan, 2014, PloS one.